Home / Healthcare / Foot and Mouth Disease (FMD) Vaccine Market
Foot and Mouth Disease (FMD) Vaccine Market Size, Share and Global Trend By Animal (Bovine, Ovine, Caprine, Porcine), By Vaccine (Conventional Vaccines, Emergency Vaccines, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecast, 2024-2032
Report Format: PDF | Published Date: Ongoing | Report ID: FBI101241 | Status : UpcomingFoot and Mouth Disease (FMD) refers to a highly severe and extremely contagious viral disease. Some of the animals that are primarily affected by the Foot and Mouth Disease (FMD) virus includes pigs, sheep, goat, cows and deer or other animals with split or divided hooves.
Some of the symptoms of the disease includes the development of fever, formation of blisters on the tongue & lips, depression, excessive salivation, lameness, reluctance with respect to standing or moving and anorexia. Foot and Mouth Disease (FMD) generally does not kill the affected adult animals, but the disease weakens them and results in lower meat or milk productivity.
Foot and Mouth Disease (FMD) is considered to be a concern worldwide because it spreads quickly, resulting in severe economic losses and even a single case of the disease can close the international export markets for dairy, meat and other products. One of the critical and crucial tools for combatting the Foot and Mouth Disease (FMD) is the administration of vaccines, which is considered to be a safe and standard practice.
Global foot and mouth disease (FMD) vaccine market growth is being driven by the increasing livestock and zoonotic diseases over the past few decades owing to factors such as adverse climatic transformations and rapid globalization. According to the World Health Organization (WHO), Asian and African regions reported 55,000 people were suffering with rabies.
In addition, WHO states that the countries located around the Mediterranean Sea reported 50,000 cases of human brucellosis in the year 2003. Thus the increasing burden of zoonotic diseases coupled with the associated cost burden and initiatives taken by government organisations in order to have safe healthcare practices for livestock and companion animals breeding. These factors are anticipated to drive the foot and mouth disease (FMD) vaccines market growth.
On the flip side, stringent governmental regulations and the complications and pathogenicity associated with the improperly attenuated vaccinations are the factors that can restrain the growth in global foot and mouth disease (FMD) vaccine market.
Key Players Covered
The major companies covered in the global foot and mouth disease (FMD) vaccine market report include Godrej Agrovet Limited, Boehringer Ingelheim International GmbH, Biogenesis, Limor de Colombia, Indian Immunologicals Limited and other players.
SEGMENTATION
SEGMENTATION | DETAILS |
By Animal | · Bovine · Ovine · Caprine · Porcine · Others |
By Vaccine | · Conventional Vaccines · Emergency Vaccines · Others |
By Distribution Channel | · Hospital Pharmacies · Retail Pharmacies · Online Pharmacies |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
As per the current foot and mouth disease (FMD) vaccine market trends, conventional vaccines among the vaccine type are anticipated to register a higher market share in the global foot and mouth diseases vaccines market owing to rising adoption of oil-based vaccines due to their longer period of effectiveness and higher efficacy.
Key Insights
- Prevalence of Foot and Mouth Disease (FMD),2018, By Key Countries/ Key Regions
- Pipeline Analysis
- New Product Launches
- Regulatory Scenario by Key Countries/ Key Regions
- Key mergers and acquisitions
Regional Analysis
The global foot and mouth disease (FMD) vaccine market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the foot and mouth disease (FMD) vaccines market in 2018, followed by Europe. Asia Pacific is anticipated to grow at a comparatively higher CAGR during the forecast period due to the increasing number of livestock animals and constant efforts of market players to commercialize veterinary vaccines and increase in investment in research and development in the region. Additionally, foot and mouth disease(FMD) vaccine in Latin America and Middle East and Africa is in the nascent stage; however, unmet needs for foot and mouth disease (FMD) vaccine is expected to drive the market growth in this region.
Foot and Mouth Disease (FMD) Vaccine Industry Developments
- In June 2018, Authorities at Chandigarh Zoo is to vaccinate more than 100 animals for foot-and-mouth disease at the Mahendra Chaudhary Zoological Park, popularly known as Chhatbir Zoo, and will conduct vaccination of over 100 animals in the coming months.
- In May 2018, Scientists at the National Agricultural Research Organization have identified a new strain of a FMD virus a Southern African Territory 3 (SAT 3), which attacks livestock and causes lesions in mouth and sore feet and subsequently inhibits the animals’ abilities to eat or move.
- Global
- 2023
- 2019-2022